Luis Chu
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
-
- Renal cell carcinoma treatment 3
- Oncology 8
- Colorectal Cancer Treatments and Studies 5
- Cancer Treatment and Pharmacology 4
- Co-authors
- Louis Fehrenbacher (2 shared papers)Michael J. O’Connell (2 shared papers)Nicholas J. Petrelli (2 shared papers)Samia Lopa (2 shared papers)Linda H. Colangelo (2 shared papers)Carmen J. Allegra (2 shared papers)Catherine A. Azar (2 shared papers)Norman Wolmark (3 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Cancer (2 papers)Blood (2 papers)Death Studies (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesCanadaIreland
In The Last Decade
Luis Chu
17 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 82
- Oncology 797
- Cancer Research 412
- Pathology and Forensic Medicine 309
- Pulmonary and Respiratory Medicine 539
- Hepatology 108
Countries citing papers authored by Luis Chu
This map shows the geographic impact of Luis Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Chu more than expected).
Fields of papers citing papers by Luis Chu
This network shows the impact of papers produced by Luis Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Chu. The network helps show where Luis Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Luis Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 410 | |
| 2 | 2009 | 200 | |
| 3 | 2010 | 193 | |
| 4 | 1998 | 193 | |
| 5 | 2011 | 185 | |
| 6 | 2008 | 89 | |
| 7 | 2005 | 43 | |
| 8 | 2010 | 33 | |
| 9 | Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer. | 1995 | 28 |
| 10 | 2010 | 20 | |
| 11 | 2007 | 19 | |
| 12 | 1989 | 15 | |
| 13 | Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer. | 1996 | 11 |
| 14 | 2012 | 7 | |
| 15 | 2013 | 4 | |
| 16 | 2017 | 1 | |
| 17 | 2011 | 1 | |
| 18 | 2015 | 0 |
About Luis Chu
Luis Chu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Molecular Biology and Economics and Econometrics, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (4 papers), Multiple Myeloma Research and Treatments (4 papers), Economic and Financial Impacts of Cancer (3 papers), Renal cell carcinoma treatment (3 papers), Breast Cancer Treatment Studies (2 papers), Cancer therapeutics and mechanisms (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Oncology (797 citations), Cancer Research (412 citations), Pathology and Forensic Medicine (309 citations), Pulmonary and Respiratory Medicine (539 citations) and Hepatology (108 citations). Luis Chu has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include Louis Fehrenbacher, Michael J. O’Connell, Nicholas J. Petrelli, Samia Lopa, Linda H. Colangelo, Carmen J. Allegra, Catherine A. Azar, Norman Wolmark, James N. Atkins and Saima Sharif. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Blood, Death Studies and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.